2603 related articles for article (PubMed ID: 25829039)
1. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
[TBL] [Abstract][Full Text] [Related]
3. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
[TBL] [Abstract][Full Text] [Related]
4. Characterization of extended spectrum β-lactamase-producing Escherichia coli in community-acquired urinary tract infections in Tunisia.
Hammami S; Saidani M; Ferjeni S; Aissa I; Slim A; Boutiba-Ben Boubaker I
Microb Drug Resist; 2013 Jun; 19(3):231-6. PubMed ID: 23363379
[TBL] [Abstract][Full Text] [Related]
5. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
Peirano G; Costello M; Pitout JD
Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
[TBL] [Abstract][Full Text] [Related]
7. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
Smet A; Martel A; Persoons D; Dewulf J; Heyndrickx M; Claeys G; Lontie M; Van Meensel B; Herman L; Haesebrouck F; Butaye P
Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
[TBL] [Abstract][Full Text] [Related]
8. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.
Yumuk Z; Afacan G; Nicolas-Chanoine MH; Sotto A; Lavigne JP
J Antimicrob Chemother; 2008 Aug; 62(2):284-8. PubMed ID: 18453527
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
[TBL] [Abstract][Full Text] [Related]
10. Emergence of extended spectrum-β-lactamase-producing Escherichia coli O25b-ST131: a major community-acquired uropathogen in infants.
Cheng MF; Chen WL; Hung WY; Huang IF; Chiou YH; Chen YS; Lee SS; Hung CH; Wang JL
Pediatr Infect Dis J; 2015 May; 34(5):469-75. PubMed ID: 25879646
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study.
Simner PJ; Zhanel GG; Pitout J; Tailor F; McCracken M; Mulvey MR; Lagacé-Wiens PR; Adam HJ; Hoban DJ;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):326-34. PubMed ID: 21353961
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
[TBL] [Abstract][Full Text] [Related]
13. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
Smith SP; Manges AR; Riley LW
Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
[TBL] [Abstract][Full Text] [Related]
14. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
[TBL] [Abstract][Full Text] [Related]
15. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway.
Naseer U; Haldorsen B; Simonsen GS; Sundsfjord A
Clin Microbiol Infect; 2010 Feb; 16(2):171-8. PubMed ID: 19548922
[TBL] [Abstract][Full Text] [Related]
16. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
[TBL] [Abstract][Full Text] [Related]
17. Fecal carriage of extended-spectrum β-lactamases and AmpC-producing Escherichia coli in a Libyan community.
Ahmed SF; Ali MM; Mohamed ZK; Moussa TA; Klena JD
Ann Clin Microbiol Antimicrob; 2014 Jun; 13():22. PubMed ID: 24934873
[TBL] [Abstract][Full Text] [Related]
18. Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary.
Pitout JD; Gregson DB; Church DL; Laupland KB
Emerg Infect Dis; 2007 Mar; 13(3):443-8. PubMed ID: 17552098
[TBL] [Abstract][Full Text] [Related]
19. Emergence of fosfomycin resistance among isolates of Escherichia coli harboring extended-spectrum and AmpC β-lactamases.
Bahramian A; Eslami G; Hashemi A; Tabibi A; Heidary M
Acta Microbiol Immunol Hung; 2018 Mar; 65(1):15-25. PubMed ID: 29137487
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS
Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]